ACA
CRDF icon

Avoro Capital Advisors’s Cardiff Oncology CRDF Stock Holding History

Avoro Capital Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000,000
Closed -$5.01M – 50
2020
Q2 		$5.01M Buy
+1,000,000
New +$2.05M 0.1% 43
2015
Q2 		– Sell
-4,496
Closed -$2.21M – 32
2015
Q1 		$2.21M Buy
+4,496
New +$1.92M 0.85% 26

Other funds holding CRDF

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Avoro Capital Advisors's CRDF Position: Q3 2020 in Review

Avoro Capital Advisors sold out of Cardiff Oncology (CRDF) in Q3 2020, closing a stake of 1,000,000 shares — an estimated $5.01M sold.

Avoro Capital Advisors first reported a position in CRDF in Q1 2015 and held it in 2 quarters. The position peaked at $5.01M in Q2 2020. 67 funds tracked by Wall St. Rank hold CRDF as of Q3 2020.

  • Avoro Capital Advisors reported no remaining Cardiff Oncology position as of Q3 2020 after selling out during the quarter.
  • Avoro Capital Advisors sold 1,000,000 Cardiff Oncology shares in Q3 2020, an estimated $5.01M.
  • Avoro Capital Advisors first reported a position in Cardiff Oncology in Q1 2015 and held it in 2 quarters.
  • Avoro Capital Advisors's Cardiff Oncology position peaked at $5.01M in Q2 2020.
  • 67 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2020.

Based on Avoro Capital Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.